2월 15, 2022 Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
12월 21, 2021 Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
12월 2, 2021 Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances